NCT04987463 2024-02-08
ViRap
Children's Memorial Health Institute, Poland
Phase 2/3 Unknown
Clinical Trials
13 trialsNCT05324384 2024-01-24
Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma
West China Hospital
Phase 2 Unknown
NCT04888741 2023-09-28
MoTD
University of Birmingham
Phase 2 Unknown
NCT03217669 2023-05-03
Epacadostat (INCB24360) in Combination With Sirolimus in Advanced Malignancy
University of Kansas Medical Center
Phase 1 Unknown
NCT05625919 2022-11-28
A Study of Safety and Efficacy of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1/2 Unknown
NCT05508620 2022-08-23
A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1 Unknown
NCT03805399 2022-08-10
FUTURE
Fudan University
Phase 1/2 Unknown
NCT05125523 2022-01-25
A Study of Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1 Unknown
NCT03781050 2019-01-23
Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome
Peking Union Medical College Hospital
Phase 4 Unknown
NCT03662412 2018-09-07
Study of Sirolimus in Patients With Advanced Pancreatic Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1/2 Unknown
NCT03500367 2018-04-18
Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis
Peking Union Medical College Hospital
Phase 4 Unknown
NCT00490789 2008-04-30
TESSTAL
Cardiff University
Phase 2 Unknown
NCT00554125 2007-11-06
Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria
Fudan University
Phase 3 Unknown